Private Advisor Group, LLC Cytom X Therapeutics, Inc. Transaction History

Private Advisor Group, LLC

$15.8 Billion
Q1 2025

A detailed history of Private Advisor Group, LLC transactions in Cytom X Therapeutics, Inc. stock. As of the latest transaction made, Private Advisor Group, LLC holds 44,002 shares of CTMX stock, worth $101,644. This represents 0.0% of its overall portfolio holdings.

Number of Shares

44,002

Previous 44,002 -0.0%

Holding current value

$101,644

Previous $45,000 37.78%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 31, 2025	SELL	$0.86 - $1.29 $7,032 - $10,548	-8,177 Reduced 15.67%	44,002 $45,000
Q2 2024 Aug 05, 2024	SELL	$1.21 - $5.13 $20,570 - $87,210	-17,000 Reduced 24.57%	52,179 $63,000
Q1 2024 Apr 30, 2024	SELL	$1.41 - $2.74 $5,640 - $10,960	-4,000 Reduced 5.47%	69,179 $150,000
Q1 2023 May 10, 2023	SELL	$1.48 - $2.88 $14,800 - $28,800	-10,000 Reduced 12.02%	73,179 $110,000
Q3 2022 Oct 14, 2022	SELL	$1.23 - $1.97 $1,230 - $1,970	-1,000 Reduced 1.19%	83,179 $121,000
Q4 2021 Feb 10, 2022	SELL	$3.87 - $7.39 $155,484 - $296,908	-40,177 Reduced 32.31%	84,179 $365,000
Q3 2021 Oct 14, 2021	BUY	$4.32 - $6.43 $173,564 - $258,338	40,177 Added 47.73%	124,356 $634,000
Q2 2021 Aug 12, 2021	SELL	$6.33 - $9.91 $6,330 - $9,910	-1,000 Reduced 1.17%	84,179 $533,000
Q1 2021 Apr 22, 2021	SELL	$6.6 - $9.0 $13,173 - $17,964	-1,996 Reduced 2.29%	85,179 $658,000
Q4 2020 Apr 01, 2021	SELL	$6.47 - $7.9 $155,299 - $189,623	-24,003 Reduced 21.59%	87,175 $571,000
Q3 2020 Nov 02, 2020	SELL	$6.55 - $8.83 $144,093 - $194,251	-21,999 Reduced 16.52%	111,178 $815,000
Q2 2020 Aug 17, 2020	SELL	$7.4 - $14.64 $59,200 - $117,120	-8,000 Reduced 5.67%	133,177 $1.11 Million
Q1 2020 May 12, 2020	SELL	$3.61 - $8.6 $3,610 - $8,600	-1,000 Reduced 0.7%	141,177 $1.08 Million
Q4 2019 Feb 10, 2020	SELL	$5.17 - $8.91 $480 - $828	-93 Reduced 0.07%	142,177 $1.18 Million
Q3 2019 Nov 13, 2019	SELL	$7.38 - $12.25 $36,900 - $61,250	-5,000 Reduced 3.4%	142,270 $991,000
Q2 2019 Aug 14, 2019	SELL	$9.35 - $11.41 $148,730 - $181,498	-15,907 Reduced 9.75%	147,270 $1.65 Million
Q1 2019 May 13, 2019	SELL	$9.5 - $19.16 $788 - $1,590	-83 Reduced 0.05%	163,177 $2.34 Million
Q4 2018 Feb 11, 2019	BUY	$12.69 - $18.61 $1,053 - $1,544	83 Added 0.05%	163,260 $2.47 Million
Q3 2018 Nov 01, 2018	SELL	$18.04 - $26.41 $37,054 - $54,246	-2,054 Reduced 1.24%	163,177 $3.02 Million
Q2 2018 Aug 09, 2018	BUY	$21.38 - $29.68 $3.53 Million - $4.9 Million	165,231 New	165,231 $3.84 Million
Q1 2018 May 09, 2018	SELL	$21.76 - $34.22 $4.03 Million - $6.34 Million	-185,187 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$13.53 - $18.17 $1.15 Million - $1.55 Million	85,187 Added 85.19%	185,187 $3.66 Million
Q2 2017 Aug 10, 2017	BUY	N/A	100,000	100,000 $1.64 Million

Others Institutions Holding CTMX

# of Institutions

Shares Held

44.9M

Call Options Held

8.9K

Put Options Held

47.9K

View Full List

About CytomX Therapeutics, Inc.

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $152M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

More about CTMX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Advisor Group, LLC with notifications on news.

Account

Private Advisor Group, LLC Cytom X Therapeutics, Inc. Transaction History